Insider Transactions in Q3 2022 at Therapeutics Md, Inc. (TXMD)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
7,000
+24.14%
|
$7,000,000
$1000.0 P/Share
|
|
Aug 18
2022
|
Paul Bisaro Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,984
+25.09%
|
-
|
|
Aug 18
2022
|
Tommy G Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,976
+33.33%
|
-
|
|
Aug 18
2022
|
Karen Ling Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,984
+30.17%
|
-
|
|
Aug 18
2022
|
Angus C. Russell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,984
+25.51%
|
-
|
|
Aug 18
2022
|
Jules A. Musing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,984
+33.03%
|
-
|
|
Aug 18
2022
|
Gail K Naughton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,984
+33.59%
|
-
|
|
Aug 18
2022
|
Cooper C. Collins |
BUY
Exercise of conversion of derivative security
|
Direct |
1,984
+4.07%
|
-
|
|
Jul 29
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+50.0%
|
$12,330,000
$822.21 P/Share
|
|
Jul 29
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
565,000
+24.71%
|
$2,260,000
$4.72 P/Share
|
|
Jul 18
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
17,688
+1.51%
|
$106,128
$6.03 P/Share
|
|
Jul 15
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
64,892
+5.39%
|
$324,460
$5.56 P/Share
|